Financials data is unavailable for this security.
View more
Year on year Dis-Chem Pharmacies Ltd had little change in net income (from 1.00bn to 984.48m) despite revenues that grew 11.08% from 32.66bn to 36.28bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 76.77% to 77.35%.
| Gross margin | 22.66% |
|---|---|
| Net profit margin | 2.89% |
| Operating margin | 5.09% |
| Return on assets | 6.32% |
|---|---|
| Return on equity | 23.49% |
| Return on investment | 13.58% |
More ▼
Cash flow in ZARView more
Cash flow information is not available for Dis-Chem Pharmacies Ltd .
| Cash flow per share | 2.56 |
|---|---|
| Price/Cash flow per share | 14.57 |
| Book value per share | 5.64 |
|---|---|
| Tangible book value per share | 4.04 |
More ▼
Balance sheet in ZARView more
| Current ratio | 1.19 |
|---|---|
| Quick ratio | 0.4113 |
| Total debt/total equity | 1.11 |
|---|---|
| Total debt/total capital | 0.5253 |
More ▼
Growth rates in ZAR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -1.80% and -1.38%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.29% |
|---|---|
| Div growth rate (5 year) | 6.00% |
| Payout ratio (TTM) | 33.74% |
| EPS growth(5 years) | 6.54 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 18.35 |
More ▼
